Voveran Emulgel 30gm Information
Voveran Emulgel 30gm is a commercial drug that is prescribed in the form of Gel. It is primarily used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. Secondary and off-label uses of Voveran Emulgel 30gm have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Voveran Emulgel 30gm. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Voveran Emulgel 30gm can also lead to other problems, which have been listed below. Such side effects of Voveran Emulgel 30gm normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Voveran Emulgel 30gm has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Voveran Emulgel 30gm's effects on the liver, heart and kidney are discussed below in the Voveran Emulgel 30gm related warnings section.
Voveran Emulgel 30gm is contraindicated in people with pre-existing medical conditions like Stomach Infection, Skin Rash, Stroke as it can result in adverse effects. Other contraindications of Voveran Emulgel 30gm have been discussed in the sections ahead.
Besides this, Voveran Emulgel 30gm may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Voveran Emulgel 30gm, it is important to know that it is safe while driving, and is habit-forming.
Voveran Emulgel 30gm Benefits & Uses
Voveran Emulgel 30gm is used to treat the following -
Main Benefits
- Muscle Pain (Read More - Home Remedies for Muscle Aches)
- Toothache (Read More - Home remedies for toothache)
- Rheumatic Pain
Other Benefits
- Headache
- Joint Pain (Read More - How to Relieve Joint Pain Naturally: Best Home Remedies)
- Osteoarthritis
- Rheumatoid Arthritis
- Ankylosing spondylitis
- Gout (Read More - Home remedies for gout pain)
- Migraine (Read More - Home remedies for migraines)
- Leg Pain (Read More - Home remedies for leg pain and weakness)
- Body Pain (Read More - Home Remedies for Body Pain)
- Sciatica (Read More - Home Remedies for Sciatica: Alleviate Pain Naturally)
- Foot Pain (Read More - How to Ease Foot Pain at Home with Natural Techniques)
Voveran Emulgel 30gm Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Voveran Emulgel 30gm Side Effects
Based on research, the following side effects have been observed when Voveran Emulgel 30gm is used -
Severe
- Nephrotoxic
- Constipation (Read More - Home remedies for constipation)
- Diarrhoea
- Pancreatic inflammation
- Liver Damage
Moderate
- Fluid Retention
- पेट दर्द
- Arrhythimia
Mild
- Skin Rash (Read More - DIY Skin Rash Relief: Simple Home Remedies That Work)
- Nausea or vomiting
Voveran Emulgel 30gm Related Warnings
-
Is the use of Voveran Emulgel 30gm safe for pregnant women?
Pregnant women may get severe side effects after taking Voveran. If you are pregnant, do not take Voveran without a doctor's advice.
Severe -
Is the use of Voveran Emulgel 30gm safe during breastfeeding?
Voveran may have very limited harmful effects for breastfeeding women.
Mild -
What is the effect of Voveran Emulgel 30gm on the Kidneys?
There may be some severe side effects of Voveran on your kidney. Do not take it unless a doctor says so.
Severe -
What is the effect of Voveran Emulgel 30gm on the Liver?
Voveran can cause side effects that could harm the liver. So medical advice before taking it is necessary.
Severe -
What is the effect of Voveran Emulgel 30gm on the Heart?
Voveran may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Moderate
Severe Interaction of Voveran Emulgel 30gm with Other Drugs
Voveran Emulgel 30gm should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Voveran Emulgel 30gm Contraindications
If you are suffering from any of the following diseases, you should not take Voveran Emulgel 30gm unless your doctor advises you to do so -
- Edema
- Stomach Infection
- Gastrointestinal Bleeding
- Kidney Disease
- Skin Rash
- Heart Attack
- Stroke
- Asthma
- Anemia
- Heart Failure
- Liver Disease
- Peptic Ulcer
Frequently asked Questions about Voveran Emulgel 30gm
-
Is this Voveran Emulgel 30gm habit forming or addictive?
Forming a habit of Voveran Emulgel 30gm has not been reported.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Voveran Emulgel 30gm since it will not make you feel sleepy.
Safe -
Is it safe?
Yes, but take Voveran Emulgel 30gm only as per medical advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Voveran Emulgel 30gm is not used to treat mental disorders.
No
Voveran Emulgel 30gm Interactions with Food and Alcohol
-
Interaction between Food and Voveran Emulgel 30gm
There isn't any research available on the side effects of taking Voveran Emulgel 30gm with food.
Unknown -
Interaction between Alcohol and Voveran Emulgel 30gm
Taking Voveran Emulgel 30gm with alcohol can have severely harmful effects on your health.
Severe
See all substitutes for Voveran
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
